You are here
The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.
SBC: ALPHA-GAMMA TECHNOLOGIES, INC. Topic: CBD04113
DNA microarray technology, in combination with statistical and predictive modeling tools, could be used to evaluate thousands of genes against distinct gene expression patterns induced by chemical/biological agents to provide early identification and speed therapeutic intervention. The overall objective of this Phase II effort is to leverage existing public domain resources and commercial tools t ...SBIR Phase II 2005 Department of DefenseOffice for Chemical and Biological Defense
SBC: MANNING APPLIED TECHNOLOGY Topic: CBD05112
Manning Applied Technology proposes to develop a handheld infrared spectrometer, ideally suited to detection of airborne chemical agents at and below permissible exposure limits. This approach offers unmatched sensitivity and specificity for detection of all types of chemical vapors. The instrument is modular, rugged, compact and highly sensitive. Volume pricing will be less than $1000 each. ...SBIR Phase I 2005 Department of DefenseOffice for Chemical and Biological Defense
SBC: NEUPHARMA, INC. Topic: CBD05116
The overall objective of this proposal is to demonstrated that imidazenil is a more potent and safer protective agent than diazepam against chemical warfare nerve agent (CWNA)-induced seizure/status epilepticus, neuropathology, and neurobehavioral deficits. Thus we will compare the dose-dependent efficacy of imidazenil or diazepam administered alone and in combination with levetiracetam in protect ...SBIR Phase I 2005 Department of DefenseOffice for Chemical and Biological Defense